Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive interim data from phase I study of ALT-801 in overweight and obese volunteers

June 17, 2021

Daiichi Sankyo discontinues development of nafamostat inhalation formulation for COVID-19 in Japan

June 16, 2021

SOX2 predicts laryngeal cancer risk in patients with premalignant lesions

June 16, 2021

Mnemo Therapeutics to accelerate development of EnfiniT platform

June 16, 2021

Spero initiates new phase I trials of SPR-206 for MDR Gram-negative infections

June 16, 2021

Servier and Oncodesign's collaboration in Parkinson's selects preclinical candidate

June 16, 2021

Harbour BioMed and Dana-Farber Cancer Institute to codevelop novel biotherapies for cancer

June 16, 2021

Ashvattha reports phase II interim data on OP-101 to treat hyperinflammation in severe COVID-19

June 16, 2021

ORIN-1001 shows promising preliminary antitumor activity in heavily pretreated solid tumors

June 16, 2021

First-in-human data for FLT3 inhibitor FF-10101

June 16, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...